tgrx-326
Small moleculeexperimental
Clinical trial activity
5 trials · 28 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Apr 23, 2021 (NCT05441956)
Timeline
Indications
Studied for
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06438367 | Phase 1 | Jun 15, 2024 | Government of China, Soochow University |
| NCT06294561 | Phase 1 | Mar 4, 2024 | Government of China, Nanjing Medical University, Nanjing University |
| NCT06082635 | Phase 3 | Nov 30, 2023 | Government of China, Sun Yat-Sen University |
| NCT05955391 | Phase 2 | Jan 18, 2023 | Bengbu Medical College, Cancer Hospital of Yunnan provinceal, Central South University, China Medical University, Chinese Academy of Medical Sciences, Dalian Medical University, Fujian Medical University, Government of China, Guizhou Medical University, Henan Medical University, Huazhong University of Science and Technology, Jiangxi Provincial Cancer Hospital, Jiao Tong University, Jilin Provincial Tumor Hospital, Mianyang Central Hospital, Ningbo No. 1 Hospital, People's Liberation Army of China, Qingdao University, Shandong University, Shijiazhuang People's Hospital, Sichuan University, Sun Yat-Sen University, University of Electronic Science and Technology of China, Zhejiang University, Zhengzhou University |
| NCT05441956 | Phase 1 | Apr 23, 2021 | Government of China, Sun Yat-Sen University |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (28)
28 organizations
Page 1 / 2